about
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV InfectioneIF5A isoforms and cancer: two brothers for two functions?Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trialsNanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.Role of DNA repair machinery and p53 in the testicular germ cell cancer: a reviewEffect of small molecules modulating androgen receptor (SARMs) in human prostate cancer modelsThe synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrenceAnalysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomicsCarcinogenetic mechanisms of endocrine disruptors in female cancers (Review)Micrornas in prostate cancer: an overview.Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesTemporal bone meningioma involving the middle ear: A case reportWeekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trialConcomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifeA mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives.Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials.Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitroSerum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case reportModulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.Short-term diet and moderate exercise in young overweight men modulate cardiocyte and hepatocarcinoma survival by oxidative stress.The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidPrognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximabOxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR.In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myelomaVascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy.Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients.The role of somatostatin receptors in the medical treatment of acromegaly.Atypical amplification of chromosome region 22q12 in melanoma: A case report.Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review article.Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article.Acetylation of proteins as novel target for antitumor therapy: review article.
P50
Q26749811-5EA06E24-3360-41CB-94A2-14428CCC4917Q26830163-FC457829-B315-4CB6-8460-D6B435683002Q26858830-36E5603B-5169-41CF-B241-672BEF01BE2EQ27302083-F40C0ECA-4492-4424-9918-8BD4147F4388Q28069963-0611A226-77D8-4CDE-B305-7B87AD4289B1Q28487784-2314D1AD-73E1-40E4-A63F-9B36CCFEBB83Q28534969-8DC7716A-0C28-4E37-9D03-09C8C697844DQ28588898-7635EFBE-1CAD-4517-A96A-1DFABCB348FFQ28596765-4125C13D-2619-4DD4-8BC3-252726F16BE2Q30234658-DD55996D-E859-467A-A6F2-52BDC8F23BB8Q30234898-4896C215-6E19-41FC-8F50-86B11C041CC0Q30397712-D48B2013-09BC-4D76-A4F6-33112F5AC171Q33242985-401FEAB8-3F21-4E74-981F-FDBD24165489Q33270398-693F5C06-51C7-41B9-A307-F398365D531FQ33358187-D8C346C3-C27F-4B42-96DA-D9F5192CF4B0Q33367184-FF209E31-F1F8-446E-8498-0806DEA20D18Q33391296-29A103B5-C8C1-478E-8F86-8DED1AA85630Q33403391-1D704F7B-6014-4DB7-8852-C33F5F919F7FQ33727889-D8FA97C1-C930-4E12-A151-C03680C7E609Q33765372-E5838740-557F-4295-A5B1-9568C13E4183Q33772333-07F4DB36-D3F4-4CB4-B5EF-33E1E9BB3DBEQ33778358-E6491E21-7092-4A04-9654-2B5892EC1804Q33950156-C17C6536-F337-4843-8728-E9E669D82979Q34015600-2CD0FCB0-B003-4423-8324-3B34A5119F2EQ34100693-CDEFA3A6-1872-470F-BEB6-6A5D4FB27D2DQ34238342-1473C71F-B148-47CB-8652-7586D983C4A1Q34786475-396BDD32-AC91-4768-A0D3-B7AA38997B60Q35042379-05630960-2F00-460C-9B73-690F1F9B5A4DQ35064862-023FE450-23C1-4491-A069-7203F3CF6AACQ35108549-1C11FD43-2273-490E-9503-38E809CF9903Q35139923-824D7660-18FD-4628-AEE2-B8FEC34D7A28Q35541482-F2F1F404-9EC2-45B6-9591-032795611F7DQ35678607-1D6BCF00-5FCE-47F3-8FF9-3F6361D2D04FQ35723888-44B7507C-FD21-4EE9-B775-334D4F6B16D5Q35742519-079237EF-CB2F-4023-BCC9-657E50A0BDB2Q35743393-3B396E0C-0F15-4167-BB5E-23C3D8CDF56AQ35803794-EFD4F86F-8B41-4087-8167-EFBACC0A2058Q35854210-9C95D873-382B-495E-B472-F208C812B849Q35854252-D5E56FC7-956D-45D6-9388-0C10BBC898F5Q35854267-2D5B83C6-C777-46C0-8A7A-498C0C0D2BB3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michele Caraglia
@ast
Michele Caraglia
@en
Michele Caraglia
@es
Michele Caraglia
@sl
type
label
Michele Caraglia
@ast
Michele Caraglia
@en
Michele Caraglia
@es
Michele Caraglia
@sl
prefLabel
Michele Caraglia
@ast
Michele Caraglia
@en
Michele Caraglia
@es
Michele Caraglia
@sl
P1053
N-5670-2015
P106
P1153
7003977238
P1960
lVluGFIAAAAJ
P2038
Michele_Caraglia
P31
P3829
P496
0000-0003-2408-6091
P569
2000-01-01T00:00:00Z